Squarepoint’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-24,300
Closed -$337K 5232
2024
Q4
$337K Buy
+24,300
New +$383K ﹤0.01% 4067

Other funds holding PRTA

Squarepoint's PRTA Position: Q1 2026 in Review

Squarepoint increased its Prothena Corp (PRTA) stake by 5.9% in Q1 2026, buying an estimated $118K and bringing the position to 230,920 shares worth $2.24M. The position accounts for ﹤0.01% of the portfolio, ranked #2100.

Squarepoint first reported a position in PRTA in Q4 2015 and has held it in 23 quarters since. The position peaked at $3.8M in Q1 2023. 185 funds tracked by Wall St. Rank hold PRTA as of Q1 2026.

  • Squarepoint held 230,920 shares of Prothena Corp worth $2.24M as of Q1 2026.
  • Squarepoint bought 12,879 Prothena Corp shares in Q1 2026, an estimated $118K.
  • Prothena Corp made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #2100 holding.
  • Squarepoint first reported a position in Prothena Corp in Q4 2015 and has held it in 23 quarters since.
  • Squarepoint's Prothena Corp position peaked at $3.8M in Q1 2023.
  • 185 funds tracked by Wall St. Rank held Prothena Corp as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.